search
Back to results

Effects of Chewing Gum Against Postoperative Ileus

Primary Purpose

Pancreas Neoplasm

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
gum
Sponsored by
Assiut University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Pancreas Neoplasm

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Pancreatic or periampullary cancer and scheduled to undergo pancreaticoduodenectomy.

Exclusion Criteria:

  • 2. Ongoing treatment for mental disease 3. Diagnosed neurological injuries or diseases affecting the ability to swallow or gastric function 4. Ongoing abuse of alcohol or other drugs 5. Previously known allergies to the content of chewing gum 6. Additional surgery after primary surgery.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Other

    Arm Label

    normal

    Arm Description

    people will not use chewing gums after whipple operation

    Outcomes

    Primary Outcome Measures

    First flatus after surgery
    From day of surgery until first postoperative flatus
    Length of hospital stay
    Time Frame: From day of surgery until discharge from surgical ward

    Secondary Outcome Measures

    Full Information

    First Posted
    February 21, 2021
    Last Updated
    February 21, 2021
    Sponsor
    Assiut University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04768660
    Brief Title
    Effects of Chewing Gum Against Postoperative Ileus
    Official Title
    The Use of Non-pharmacological Agent to Accelerate Gastrointestinal Recovery in Patients Undergoing Pancreatic Head Resection
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    September 2020
    Overall Recruitment Status
    Unknown status
    Study Start Date
    February 14, 2021 (Anticipated)
    Primary Completion Date
    March 2023 (Anticipated)
    Study Completion Date
    May 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Assiut University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    The purpose of this study is to determine whether the use of chewing gum effects postoperative ileus after pancreaticoduodenectomy
    Detailed Description
    Postoperative ileus is common after surgery. One non-pharmacological intervention that has shown promising results in reducing the duration of postoperative ileus is chewing gum after surgery. However, this has not been investigated in upper gastrointestinal surgery such as pancreatic surgery. Hence the aim of this study was to investigate the effects of chewing gum treatment on patients undergoing pancreaticoduodenectomy due to pancreatic or periampullary cancer. This study was conducted as a phase-III trial. Patients diagnosed with pancreatic tumours scheduled for pancreaticoduodenectomy were included. The treatment group received chewing gum postoperatively and standard care. Controls received glucose solution and standard care.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pancreas Neoplasm

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    10 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    normal
    Arm Type
    Other
    Arm Description
    people will not use chewing gums after whipple operation
    Intervention Type
    Other
    Intervention Name(s)
    gum
    Intervention Description
    Other: Chewing gum ChiczaTM organic chewing gum 6 pieces a day Other: Glucose 12ml glucose solution (13,6g) per day
    Primary Outcome Measure Information:
    Title
    First flatus after surgery
    Description
    From day of surgery until first postoperative flatus
    Time Frame
    (with in the first 21 days)
    Title
    Length of hospital stay
    Description
    Time Frame: From day of surgery until discharge from surgical ward
    Time Frame
    (with in the first 21 days) ]

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Pancreatic or periampullary cancer and scheduled to undergo pancreaticoduodenectomy. Exclusion Criteria: 2. Ongoing treatment for mental disease 3. Diagnosed neurological injuries or diseases affecting the ability to swallow or gastric function 4. Ongoing abuse of alcohol or other drugs 5. Previously known allergies to the content of chewing gum 6. Additional surgery after primary surgery.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    andrew mokbel
    Phone
    01090981160
    Email
    andrew.sawers55@gmail.com

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Effects of Chewing Gum Against Postoperative Ileus

    We'll reach out to this number within 24 hrs